EV
Evotec SE
EVOTF · OTC
$6.69 +0.00% (+$0.00)
Market Cap 1.02B €
P/E Ratio -
Div. Yield -
ROE 26.50%
Piotroski F-Score Moderate
4/9Valuation
96 /100
Cheap P/S 1.42x
P/B 1.54x
P/E N/A
Growth
22 /100
Declining Rev. growth 1.60%
Book val. growth 11.84%
EPS growth N/A
Profitability
1 /100
Weak Gross margin 10.48%
Net margin 27.52%
FCF margin 22.56%
Quality
6 /100
Poor ROIC 10.30%
ROE 26.50%
Asset turnover 0.46x
Debt
54 /100
Moderate Debt/Equity 0.71x
Current ratio 2.33x
Int. coverage -10.81x
Stability
45 /100
Moderate Beta 1.26x
Rev. volatility 2.57%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre EVOTF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christian Wojczewski
Employees
4,553
Headquarters
Hamburg
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report